These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11170946)

  • 21. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
    Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
    Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
    Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
    Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation.
    Mossad SB; Avery RK; Longworth DL; Kuczkowski EM; McBee M; Pohlman BL; Sobecks RM; Kalaycio ME; Andresen SW; Macklis RM; Bolwell BJ
    Bone Marrow Transplant; 2001 Sep; 28(5):491-5. PubMed ID: 11593323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.
    Hassan IA; Chopra R; Swindell R; Mutton KJ
    Bone Marrow Transplant; 2003 Jul; 32(1):73-7. PubMed ID: 12815481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation.
    Kolbe K; Domkin D; Derigs HG; Bhakdi S; Huber C; Aulitzky WE
    Bone Marrow Transplant; 1997 Jan; 19(2):143-7. PubMed ID: 9116611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
    Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hickman catheter site infections after allogeneic stem cell transplantation: a single-center experience.
    Kim DH; Bae NY; Sung WJ; Kim JG; Kim SW; Baek JH; Chang HH; Sohn SK; Lee KB
    Transplant Proc; 2004 Jun; 36(5):1569-73. PubMed ID: 15251387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
    Frère P; Pereira M; Fillet G; Beguin Y
    Eur J Haematol; 2006 Feb; 76(2):102-8. PubMed ID: 16405430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious complications after simultaneous pancreas-kidney transplantation.
    Michalak G; Kwiatkowski A; Bieniasz M; Meszaros J; Czerwinski J; Wszola M; Nosek R; Ostrowski K; Chmura A; Danielewicz R; Lisik W; Adadynski L; Fesołowicz S; Dobrowolska A; Durlik M; Rowiñski W
    Transplant Proc; 2005 Oct; 37(8):3560-3. PubMed ID: 16298661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early central nervous system complications after reduced-intensity stem cell transplantation.
    Kishi Y; Miyakoshi S; Kami M; Ikeda M; Katayama Y; Murashige N; Kusumi E; Yuji K; Kobayashi K; Kato D; Hamaki T; Matsumura T; Kim SW; Morinaga S; Mori S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S;
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):561-8. PubMed ID: 15282534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
    Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell recovery after autologous stem cell transplantation.
    Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
    Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.